Virginia can now look forward to a greater range of products
Three new laws intended to expand patient access to and the therapeutic value of Virginia’s medical cannabis program take effect July 1, 2019.
“Patient access is critical to the success of Virginia’s medical cannabis program,” said Jenn Michelle Pedini, NORML’s development director and executive director of Virginia NORML. “These bills help ensure that all patients are able to obtain and use the necessary therapeutic doses of their cannabis medicines regardless of location or physical ability.”
PRODUCTS AND PRACTITIONERS
Virginia medical cannabis patients can now look forward to a greater range of products available in full therapeutic strengths thanks to Senator Dunnavant’s SB1557. Previously, Virginia’s five licensed medical cannabis providers, called pharmaceutical processors, would have been limited to dispensing only oils when they open their doors later this year. Now, patients can expect to see products typical of compounding pharmacies, like capsules, topicals, lozenges, lollipops, and suppositories, with an allowance of up to 10 milligrams of THC each.
To Read The Rest Of This Article On NORML, Click Here